Rentschler Biopharma and Coriolis Pharma Form Strategic Partnership

Rentschler Biopharma SE and Coriolis Pharma have announced a strategic collaboration to deliver integrated biopharmaceutical solutions. This partnership combines scientific and technical expertise to offer seamless service from formulation to manufacturing. Clients are expected to benefit from reduced complexity, risk, and accelerated timelines.

The collaboration responds to the increasing complexity of the biologics market, which demands integrated, science-driven solutions. By uniting their expertise, both companies aim to expedite products' path from development to market.

Coriolis Pharma brings analytical and formulation expertise, while Rentschler Biopharma contributes bioprocess and manufacturing experience. The partnership exemplifies a commitment to advancing efficient and reliable biopharmaceutical programs.

Services will be available from December 2025. The partnership will enhance offerings in key markets, including Germany and the United States.